Oncology CRO

Our unique combination of experienced staff, specialized training, regulatory understanding and broad range of services enable us to get studies and sites up to speed quickly, implement comprehensive solutions and accelerate the development pipeline.

Our integrated program services in the Americas, Europe and Asia build on long-standing relations with Key Opinion Leaders, and real-time experience at all major cancer treatment centers in those regions.

Our Niphix subsidiary is the leading oncology-focused CRO in Japan, providing an array of services to Japanese and non-Japanese sponsors.

Oncology Drug Experience

Our experience includes support of more than 500 successful oncology drug studies, at over 1,000 sites in the US, Europe and international sites, with indications in:

  • Acute Myeloid Leukemia (AML)
  • Advanced Malignancies
  • Bladder Cancer
  • Bone Marrow Transplant
  • Brain Tumor / Glioblastoma
  • Breast Cancer
  • Chronic Myelogenous Leukemia
  • Colorectal Cancer
  • Endometrial Cancer
  • Gastric Cancer
  • Hodgkin’s Disease
  • Kaposi’s Sarcoma
  • Liver Cancer
  • Lung Cancer / NSCLS / SCLC
  • Multiple Myeloma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Uterine Cancer

Medical Devices and In Vitro Diagnostics

We have worked with large and small medical device and IVD firms to support clinical studies and related US and international regulatory submissions for:

  • Breast cancer diagnostics
  • Analyzers and reagents for cancer screenings / detection of tumor-associated antigens
  • Colorectal cancer diagnostics
  • Genetic markers for detection of lung , colorectal, and bladder cancers
  • Melanoma detection